Showing results (1-10 of 644) with videos related to

Sort By:
Pageof 65
Clinical Pharmacology and Therapeutics|June 15, 2018
CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or BothStephen J Nicholls
Current Opinion in Lipidology|July 14, 2009
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronariesStephen J Nicholls
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
HDL: still a target for new therapies?Stephen J Nicholls
Current Cardiology Reports|September 28, 2011
Apo a-I modulating therapiesStephen J Nicholls
Cleveland Clinic Journal of Medicine|January 6, 2012
Is niacin ineffective? Or did AIM-HIGH miss its target?Stephen J Nicholls
Drugs|June 7, 2024
Therapeutic Potential of Lipoprotein(a) InhibitorsStephen J Nicholls
Expert Review of Cardiovascular Therapy|August 1, 2008
Rosuvastatin and progression of atherosclerosisStephen J Nicholls
Current Cardiology Reports|February 25, 2012
EvacetrapibStephen J Nicholls
Current Cardiology Reports|March 5, 2019
The New Face of Hyperlipidemia and the Role of PCSK9 InhibitorsStephen J Nicholls
Pageof 65